Drug Development

Advancing New Approach Methodologies for ethical & reliable drug development New Approach Methodologies: Changing drug development as we know it Drug development is long, expensive, and painfully inefficient. With 90% of drug candidates failing before clinical approval, the industry is desperate for human-relevant, predictive tools—this is where New Approach Methodologies (NAMs) have emerged as a vital solution. At Genoskin, weRead more

Genoskin launches MANTIS^®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS^® (Multiplex ANnotated Tissue Imaging System) platform was developed at Infinity (Inserm U1291, France) by a team of experts under the guidance of Dr. Nicolas Gaudenzio, who was recently appointed as our Chief Scientific Officer (CSO).